The medicine company - advance the development of a portfolio of anti-infective programs.

Active Definitive Contract Awarded Last action

Contract number
HHSO100201600026C
Awardee
Awarding agency
Obligated
$98,144,230

Award facts

Opportunity
  • BAA16100SOL00001 Solicitation number
Contract value 100% obligated
$98,144,230.00 Current and potential, with all options
Completion date 72% complete
Current and potential, with all options
Contracting staff
Set-aside
No set-aside
Competition
Full and Open Competition · 1 offer Negotiated Proposal / Quote
Pricing
Cost Sharing
Place of performance
Parsippany, NJ 07054, USA
Legislative mandates

Award details come from SAM.gov/FPDS.

Transactions

Action Obligated Date
Supplemental Agreement for work within scope P00011 · Updates the address of qpex/the medicines company; update the PI and deputy PI; update the JOC membership; update the non-voting members, update alternate… $0
Other Administrative Action P00010 $0
Supplemental Agreement for work within scope P00009 $10,000,000
Supplemental Agreement for work within scope P00008 $0
Exercise an Option P00007 · Modification 7 performs the following actions: 1.) activates option 4 (clin 0005) for program management, non-clinical toxicology, non-clinical, clinical,… $6,144,230
Exercise an Option P00006 · Modification 6 performs the following actions: 1.) activates option 3 (clin 0004) for program management, non-clinical toxicology, non-clinical, clinical,… $15,000,000
Funding Only Action P00005 · Modification 5 performs the following actions: 1.) activates option 2 (clin 0003) for the manufacturing of phase 3 clinical trial material 2.) removes earned… $15,000,000
Supplemental Agreement for work within scope P00004 $20,000,000
Supplemental Agreement for work within scope 3 · The medicines company (SAN diego), LLC,- advance the development of a portfolio of anti-infective programs. $0
Other Administrative Action 1 $0
Supplemental Agreement for work within scope 2 $0
Original award $32,000,000
Show all 12

About this award

This is a definitive cost-sharing contract awarded by the Department of Health and Human Services' Office of the Assistant Secretary for Preparedness and Response to The Medicines Company. The contract, which does not have a set-aside designation, is valued at $98,144,230.00 and runs through September 30, 2030. The purpose of the contract is to advance the development of The Medicines Company's portfolio of anti-infective programs. The contract updates the address, principal investigator, and other administrative details related to the contract.

Quick answers

Who was awarded contract HHSO100201600026C?

HHSO100201600026C was awarded to The Medicines Company by Office of the Assistant Secretary for Preparedness and Response (Department of Health and Human Services) on September 15, 2016.

How much is contract HHSO100201600026C worth?

The government has obligated $98,144,230 on HHSO100201600026C.

Was contract HHSO100201600026C competed?

The extent of competition for HHSO100201600026C was full and open competition. The government received 1 offer.

On GovTribe

See this award's full record

  • Every transaction and funding action
  • The awardee's other awards and teaming partners
  • Similar awards and recompete opportunities
  • Ask GovTribe AI about this award